Attralus, Inc.: Clinical Trials

7 trials sponsored by Attralus, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 recruiting. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1
Phase 12Completed 1, Unknown 1

Follow Attralus, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome
124I-evuzamitide - Lumbar Spinal Stenosis, Carpal Tunnel Syndrome (CTS)
Phase 2Enrolling by invitationUniversity of Tennessee Graduate School of Medicine402025-05-222026-07-21
A Study of AT-02 in Subjects With Systemic Amyloidosis.
AT02 - Amyloidosis; Systemic
Phase 2Active not recruitingAttralus, Inc.1202023-09-212026-05-06
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
124I-Evuzamitide - Amyloidosis, Transthyretin Amyloidosis
Phase 2RecruitingOregon Health and Science University1502023-01-102026-04-13
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
AT-02, AT-02 (Placebo) - Amyloidosis; Systemic
Phase 1UnknownAttralus, Inc.1002022-09-012024-04-03
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
I 124-Evuzamitide - Transthyretin Amyloidosis
Phase 2CompletedColumbia University102022-07-082025-07-18
A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis
124I-AT-01 - Amyloidosis
Phase 2CompletedAttralus, Inc.332021-11-302025-09-04
A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis
124I-AT03 - Amyloidosis; Systemic
Phase 1CompletedAttralus, Inc.132021-11-302022-09-15

Conditions studied

Amyloidosis (3)  ·  Amyloidosis, Hereditary, Transthyretin-Related (3)  ·  Immunoglobulin Light-chain Amyloidosis (3)  ·  Amyloid Neuropathies, Familial (1)  ·  Carpal Tunnel Syndrome (1)  ·  Spinal Stenosis (1)

Countries

United States (7)  ·  Australia (1)

Top investigators

Emily B. Martin, PhD (1)  ·  Gregory Bell, MD (1)  ·  Gregory M. Bell, MD (1)  ·  Mathew Maurer, MD (1)

Results publications

PMID 40439628, PMID 42670739